IP Library Granted Patent US 7,732,585
Granted Patent B2
US 7,732,585 · App. 11/582,836 · Granted Jun 8, 2010

Altered recombinases for genome modification

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,732,585
App. No.
11/582,836
Granted
Jun 8, 2010
Kind
B2
Abstract

The present invention describes methods of identifying altered recombinases and compositions thereof, wherein at least one amino acid is different from a parent, wild-type recombinase and the altered recombinase has improved recombination efficiency towards wild-type and/or pseudo att site sequences relative to the parent, wild-type recombinase. The present invention also includes methods of modifying the genomes of cells using the altered recombinases, including methods of site-specifically integrating a polynucleotide sequence of interest in a genome of a eucaryotic cell.

Claims (9)

1. A nucleic acid encoding an altered unidirectional site-specific bacteriophage integrase chosen from the group consisting of SEQ ID NO:22, SEQ ID NO:23, and SEQ ID NO:24, that has integrase activity,

wherein said altered unidirectional site-specific bacteriophage integrase has improved recombination efficiency towards wild-type or pseudo attachment sites as compared to a corresponding wild-type unidirectional site-specific bacteriophage integrase.

2. The nucleic acid according to claim 1 , wherein said nucleic acid is isolated.

3. An expression cassette, comprising:

(a) a transcriptional initiation region functional in an expression host;

(b) a nucleic acid encoding an altered unidirectional site-specific bacteriophage integrase chosen from the group consisting of SEQ ID NO:22, SEQ ID NO:23, and SEQ ID NO:24, that has integrase activity, wherein said altered unidirectional site-specific bacteriophage integrase has improved recombination efficiency towards wild-type or pseudo attachment sites as compared to a corresponding wild-type unidirectional site-specific bacteriophage integrase, and

(c) a transcriptional termination region functional in said expression host.

4. A kit comprising: a nucleic acid encoding an altered unidirectional site-specific bacteriophage integrase chosen from the group consisting of SEQ ID NO:22, SEQ ID NO:23, and SEQ ID NO:24, that has integrase activity,

wherein said altered unidirectional site-specific bacteriophage integrase has improved recombination efficiency towards wild-type or pseudo attachment sites as compared to a corresponding wild-type unidirectional site-specific bacteriophage integrase, and instructions for using said nucleic acid.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 8, 2012
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027674/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2006
From: CALOS, MICHELE PAMELA
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 018621/0386 →
Continuity (4)
Continuation 1083632300 · Apr 29, 2004
Continuation 0978829700 · Feb 16, 2001
Provisional Application 6018375900 · Feb 18, 2000
Related Publication 20070077589A1 · Apr 5, 2007